LUCA SCIENCE INC has a total of 13 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are MOHAPATRA SHYAM S, DONALD CARLTON D and ZON LEONARD I.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | United States | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Analysing materials | |
#5 | Measuring microorganism processes | |
#6 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Harashima Hideyoshi | 11 |
#2 | Yamada Yuma | 11 |
#3 | Osaka Hitoshi | 4 |
#4 | Abe Jiro | 4 |
#5 | Somiya Kana | 4 |
#6 | Takeda Atsuhito | 4 |
#7 | Suganuma Masashi | 2 |
#8 | Ohta Yoshihiro | 2 |
#9 | Sasaki Daisuke | 1 |
#10 | Hibino Mitsue | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021015298A1 | Method of obtaining mitochondria from cells and obtained mitochondria | |
WO2020230601A1 | Kit including primer dna set for detecting mitochondrial ribosomal rna mutation, nucleic acid for expressing mitochondrial ribosomal rna, lipid membrane structure obtained by encapsulating the nucleic acid, and uses of these | |
WO2020203961A1 | Lipid membrane structure and manufacturing method therefor | |
WO2020054829A1 | Transplantation of mitochondria into lymphoid organ and composition therefor | |
WO2020054824A1 | Method for measuring activity of mitochondrial respiratory complex | |
TW202000240A | Nucleic acid for expression of protein in mitochondria, lipid membrane structure having said nucleic acid encapsulated therein and their use | |
CA3049099A1 | Method for producing myocardial stem cell for use in treatment and/or prevention of cardiac arrest |